|
|
DSpace at RU >
Browsing by Author Wit, J.M.
Showing results 7 to 26 of 34
| Full Text | Issue Date | Title | Author(s) | | 1997 | Effect of growth hormone treatment on craniofacial growth in Turner's syndrome | Rongen, C.; Born, E. van de; Prahl-Andersen, B., et al |
| 2010 | The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome. | Menke, L.A.; Sas, T.C.J.; Zandwijken, G.R., et al |
| 2011 | Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome | Menke, L.A.; Sas, T.C.J.; Stijnen, T., et al |
| 2011 | The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome | Menke, L.A.; Sas, T.C.J.; Koningsbrugge, S.H. van, et al |
| 2010 | The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome. | Menke, L.A.; Sas, T.C.J.; Visser, M. de, et al |
| 2009 | Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. | Lind van Wijngaarden, R.F. de; Siemensma, E.P.; Festen, D.A., et al |
| 2010 | Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. | Menke, L.A.; Sas, T.C.J.; Muinck Keizer-Schrama, S.M.P.F. de, et al |
| 2011 | Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences. | Vries, M.C. de; Houtlosser, M.; Wit, J.M., et al |
| 2002 | Final height gain by GH therapy in children with idiopathic short stature is dose dependent. | Wit, J.M.; Rekers-Mombarg, L.T.M. |
| 2007 | Functional outcomes and participation in young adulthood for very preterm and very low birth weight infants: the Dutch Project on Preterm and Small for Gestational Age Infants at 19 years of age. | Hille, E.T.; Weisglas-Kuperus, N.; Goudoever, J.B. van, et al |
| 2011 | Genome-wide screening in human growth plates during puberty in one patient suggests a role for RUNX2 in epiphyseal maturation. | Emons, J.; Dutilh, B.E.; Decker, E., et al |
| 2004 | Genotype-phenotype correlation in patients suspected of having sotos syndrome. | Boer, L.M.; Kant, S.; Karperien, M., et al |
| 1997 | Growth before and during growth hormone treatment in children operated for craniopharyngioma | Hogeveen, M.; Noordam, C.; Otten, B.J., et al |
| 1995 | Growth hormone treatment in two dose regiments in girls with Turner syndrome: final height results | Massa, G.G.; Otten, B.J.; Muinck Keizer-Schrama, S.M.P.F. de, et al |
| 2008 | Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit. | Duyvenvoorde, H.A. van; Kempers, M.J.E.; Twickler, T.B., et al |
| 2009 | Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. | Domene, H.M.; Hwa, V.; Argente, J., et al |
| 2009 | Intelligence of very preterm or very low birthweight infants in young adulthood. | Weisglas-Kuperus, N.; Hille, E.T.; Duivenvoorden, H.J., et al |
| 1995 | Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone respons to secretagogues | Wit, J.M.; Boersma, B.; Muinck Keizer-Schrama, S.M.P.F. de, et al |
| 2008 | Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. | Festen, D.A.; Wevers, M.; Lindgren, A.C., et al |
| 2010 | Pediatric oncologists' attitudes towards involving adolescents in decision-making concerning research participation. | Vries, M.C. de; Wit, J.M.; Engberts, D.P., et al |
Showing results 7 to 26 of 34
|